Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)
Neuroone Medical Technologies posted quarterly Current Leases of $65768.0 for Q3 2024, down 49.06% year-on-year from $129116.0 in Q4 2023, and down 49.06% on a QoQ basis from $129116.0 in Q3 2023.
Neuroone Medical Technologies (NMTC) has 2 years of Current Leases data on file, last reported at $65768.0 in Q3 2024.
- For the quarter ending Q3 2024, Current Leases fell 49.06% year-over-year to $65768.0; the trailing twelve-month figure through Sep 2024 stood at $65768.0 (down 49.06% YoY), and the FY2024 full-year result was $65768.0, down 49.06% from the prior year.
- Current Leases for Q3 2024 stood at $65768.0, down from $129116.0 in the prior quarter.
- Across five years, Current Leases topped out at $129116.0 in Q3 2023 and bottomed at $65768.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 65,768.00 |
| Sep 30, 2023 | 129,116.00 |